3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Wilms Tumor
1
Stomach Neoplasms
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hepatic Veno-Occlusive Disease
1
Breast Neoplasms
1
Interventions
liposomal amphotericin B
2
Voriconazole
2
Vincristine
2
Therapeutics
2
Radiotherapy
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Itraconazole
2
Flow Cytometry
2
Filgrastim
2
Caspofungin
2
Amplified Fragment Length Polymorphism Analysis
2
thymoglobulin
1
sargramostim
1
ixabepilone
1
glutamic acid diethyl ester
1
entinostat
1
aldesleukin
1
Valacyclovir
1
Traumeel S
1
Stem Cell Transplantation
1
Rituximab
1
Ritonavir
1
Ribavirin
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Pentetic Acid
1
Palivizumab
1
Minocycline
1
Methylprednisolone Hemisuccinate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Hematologic Tests
×
Other hematologic neoplasm
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled